1. Home
  2. PETS vs CVM Comparison

PETS vs CVM Comparison

Compare PETS & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PetMed Express Inc.

PETS

PetMed Express Inc.

SELL

Current Price

$1.26

Market Cap

28.4M

ML Signal

SELL

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

SELL

Current Price

$1.83

Market Cap

30.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PETS
CVM
Founded
1996
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Drug Stores and Proprietary Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.4M
30.1M
IPO Year
2003
1996

Fundamental Metrics

Financial Performance
Metric
PETS
CVM
Price
$1.26
$1.83
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $12.50
AVG Volume (30 Days)
130.4K
★ 253.1K
Earning Date
08-13-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $273,800,000.00
$264,033.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.24
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 65.45
52 Week Low
$1.27
$0.89
52 Week High
$4.10
$10.24

Technical Indicators

Market Signals
Indicator
PETS
CVM
Relative Strength Index (RSI) 14.90 49.64
Support Level N/A $1.01
Resistance Level $1.91 $4.84
Average True Range (ATR) 0.04 0.26
MACD -0.01 -0.01
Stochastic Oscillator 3.28 15.88

Price Performance

Historical Comparison
PETS
CVM

About PETS PetMed Express Inc.

PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: